166
Participants
Start Date
June 6, 2024
Primary Completion Date
September 17, 2025
Study Completion Date
January 5, 2028
Amlitelimab
Pharmaceutical form: Injection solution Route of administration: SC injection
Placebo
Pharmaceutical form: Injection solution Route of administration: SC injection
Investigational Site Number : 0320004, Buenos Aires
Investigational Site Number : 0320001, Buenos Aires
Investigational Site Number : 1000001, Sofia
Investigational Site Number : 0320002, Rosario
Investigational Site Number : 0360001, Sydney
Investigational Site Number : 0360003, Melbourne
Icahn School of Medicine at Mount Sinai- Site Number : 8400003, New York
Investigational Site Number : 2760008, Berlin
Investigational Site Number : 2760007, Berlin
Investigational Site Number : 7240002, Córdoba
Investigational Site Number : 2760001, Hamburg
Investigational Site Number : 3800004, Milan
Investigational Site Number : 7240006, Madrid
Investigational Site Number : 7240008, Madrid
DJL Clinical Research - Charlotte - Park Road- Site Number : 8400013, Charlotte
Investigational Site Number : 7240007, Pozuelo de Alarcón
Investigational Site Number : 2500001, Brest
New Horizon Research Center- Site Number : 8400017, Miami
Total Skin and Beauty Dermatology Center- Site Number : 8400018, Birmingham
Investigational Site Number : 3800001, Bologna
Apex Clinical Research Center- Site Number : 8400027, Mayfield Heights
Cleveland Clinic- Site Number : 8400028, Cleveland
Dawes Fretzin Clinical Research- Site Number : 8400010, Indianapolis
Investigational Site Number : 2760003, Münster
Michigan Center for Research Company- Site Number : 8400016, Clarkston
Investigational Site Number : 2760004, Osnabrück
Health Concepts- Site Number : 8400001, Rapid City
Joel Schlessinger, PC- Site Number : 8400021, Omaha
Vital Prospects Clinical Research Institute - Tulsa- Site Number : 8400004, Tulsa
Investigational Site Number : 2500003, Paris
Investigational Site Number : 2500004, Rouen
Progressive Clinical Research - San Antonio- Site Number : 8400019, San Antonio
Investigational Site Number : 3800003, Naples
Investigational Site Number : 2760006, Augsburg
Dermatology Research Associates - Los Angeles- Site Number : 8400015, Los Angeles
UC Irvine Healthcare - Gottschalk Medical Plaza- Site Number : 8400007, Irvine
First OC Dermatology- Site Number : 8400014, Fountain Valley
Center for Dermatology Clinical Research- Site Number : 8400008, Fremont
Oregon Medical Research Center- Site Number : 8400002, Portland
Investigational Site Number : 1560001, Shanghai
Investigational Site Number : 1560006, Hangzhou
Investigational Site Number : 6420001, Cluj-Napoca
Investigational Site Number : 1560022, Chengdu
Investigational Site Number : 1520003, Santiago
Investigational Site Number : 1520001, Santiago
Investigational Site Number : 1520004, Santiago
Investigational Site Number : 1520002, Santiago
Investigational Site Number : 1240005, Calgary
Investigational Site Number : 1240007, Calgary
Investigational Site Number : 1240001, Winnipeg
Investigational Site Number : 1240003, Hamilton
Investigational Site Number : 1240006, Markham
Investigational Site Number : 2032104, Ostrava
Investigational Site Number : 2030011, Prague
Investigational Site Number : 2030012, Prague
Investigational Site Number : 2500002, Nice
Investigational Site Number : 3800002, Rome
Investigational Site Number : 3920003, Ebina-shi
Investigational Site Number : 3920001, Yokohama
Investigational Site Number : 3920001, Yokohama
Investigational Site Number : 3920002, Kamiamakusa
Investigational Site Number : 3920005, Koto-ku
Investigational Site Number : 3920004, Fukuoka
Investigational Site Number : 3920006, Tokyo
Investigational Site Number : 5280004, Rotterdam
Investigational Site Number : 7240005, Barcelona
Investigational Site Number : 7240010, Barcelona
Investigational Site Number : 7240004, Alicante
Investigational Site Number : 8260003, London
Investigational Site Number : 8260004, Salford
Investigational Site Number : 8260006, Oxford
Investigational Site Number : 8260005, Dundee
Investigational Site Number : 8260007, London
Investigational Site Number : 8260001, London
Lead Sponsor
Sanofi
INDUSTRY